Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan

BACKGROUND: There is an urgent need for treatments that can shorten hospitalization and lower the risk of secondary infection and death in patients with corona disease. The ProPac-COVID trial evaluates whether combination therapy with macrolide azithromycin and hydroxychloroquine via anti-inflammati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivapalan, Pradeesh, Ulrik, Charlotte Suppli, Lappere, Therese Sophie, Eklöf, Josefin Viktoria, Shaker, Saher Burhan, Bødtger, Uffe Christian Steinholtz, Browatzki, Andrea, Meyer, Christian Niels, Weinreich, Ulla Møller, Laursen, Christian B., Biering-Sørensen, Tor, Knop, Filip Krag, Lundgren, Jens D., Jensen, Jens-Ulrik Stæhr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573513/
https://www.ncbi.nlm.nih.gov/pubmed/33081817
http://dx.doi.org/10.1186/s13063-020-04795-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573513/
https://www.ncbi.nlm.nih.gov/pubmed/33081817
http://dx.doi.org/10.1186/s13063-020-04795-0

Ejemplares similares